Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+2.60%
-4.42%
-3.77%
+1.53%
+2.08%
Most Trending
+2.60%
-4.42%
-3.77%
+1.53%
+2.08%
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
19 Sep 2025$AGMH delivered the most spectacular performance, rocketing 370.85% to $10.50 after surging 158.74% in after-hours trading following a Form 6-K filing. AGM Group Holdings astronomical move demonstrates how regulatory filings can trigger massive speculation in micro-cap stocks. The volume explosion to over 206 million shares, compared to an average of just 946,000, suggests institutional or whale activity drove this momentum. However, such extreme moves often prove unsustainable without concrete business developments to support the valuation.
$OKLO gained 28.83% to $135.23 as the nuclear energy company benefited from growing investor confidence in small modular reactor technology. The company's inclusion in Validea's Small-Cap Growth Investor model based on Motley Fool's published strategy highlights its fundamental appeal. With volume reaching 53.37 million shares versus a 14.80 million average, institutional interest appears genuine.
$QUBT surged 26.81% to $23.27, extending its remarkable 2,300% annual gain as quantum computing enthusiasm reaches fever pitch. The company's recent NASA and NIST contracts validate its photonic chip technology and establish crucial government relationships. Trading volume of 97.17 million shares, far exceeding the 18.03 million average, indicates sustained institutional accumulation.
$SMR climbed 22.69% to $46.77 following news of a $350 billion US-UK investment commitment in nuclear and related technologies. NuScale Power's small modular reactor design positions it perfectly to capitalize on this massive capital deployment. The 50.72 million share volume, significantly above the 14.05 million average, suggests serious money is taking positions ahead of anticipated contract awards. Government backing provides crucial validation for the company's technology and business model.
$CMND advanced 19% to $1.19 after Clearmind Medicine secured a $10 million securities purchase agreement. The biotech's fundraising success provides runway for continued clinical development programs. However, the relatively modest volume of 37.35 million shares compared to recent trading patterns suggests this move lacks the conviction seen in other gainers today.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Pro Members
